{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:22:35Z","timestamp":1793247755412,"version":"4.5.0"},"reference-count":103,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Development Project of Shanghai Peak Disciplines-Integrative medicine","award":["20150407"],"award-info":[{"award-number":["20150407"]}]},{"name":"The Academy of Integrative Medicine of Fudan University"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81173390"],"award-info":[{"award-number":["81173390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Health and Family Planning Commission","award":["ZYSNXD-CC-HPGC-JD-015"],"award-info":[{"award-number":["ZYSNXD-CC-HPGC-JD-015"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Cancer is one of the leading causes of deaths worldwide. Compounds derived from traditional Chinese medicines have been an important source of anticancer drugs and adjuvant agents to potentiate the efficacy of chemotherapeutic drugs and improve the side effects of chemotherapy. Herba Epimedii is one of most popular herbs used in China traditionally for the treatment of multiple diseases, including osteoporosis, sexual dysfunction, hypertension and common inflammatory diseases. Studies show Herba Epimedii also possesses anticancer activity. Flavonol glycosides icariin and icariside II are the main bioactive components of Herba Epimedii. They have been found to possess anticancer activities against various human cancer cell lines in vitro and mouse tumor models in vivo via their effects on multiple biological pathways, including cell cycle regulation, apoptosis, angiogenesis, and metastasis, and a variety of signaling pathways including JAK2-STAT3, MAPK-ERK, and PI3k-Akt-mTOR. The review is aimed to provide an overview of the current research results supporting their therapeutic effects and to highlight the molecular targets and action mechanisms.<\/jats:p>","DOI":"10.3390\/nu8090563","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T10:10:00Z","timestamp":1473761400000},"page":"563","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II"],"prefix":"10.3390","volume":"8","author":[{"given":"Meixia","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9579-9163","authenticated-orcid":false,"given":"Jinfeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingli","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuming","family":"Mo","sequence":"additional","affiliation":[{"name":"Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubao","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcheng","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0378-8741(00)00341-X","article-title":"Plants used against cancer-an extension of Jonathan Hartwell","volume":"73","author":"Graham","year":"2000","journal-title":"J. Ethnopharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2008.20.6235","article-title":"Perspectives for cancer prevention with natural compounds","volume":"27","author":"Amin","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2184.2012.00833.x","article-title":"Plant natural compounds: Targeting pathways of autophagy as anti-cancer therapeutic agents","volume":"45","author":"Zhang","year":"2012","journal-title":"Cell Prolif."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jep.2005.05.011","article-title":"Plants as a source of anti-cancer agents","volume":"100","author":"Cragg","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kumar, A., Patil, D., Rajamohanan, P.R., and Ahmad, A. (2013). Isolation, purification and characterization of vinblastine and vincristine from endophytic fungus Fusarium oxysporum isolated from Catharanthus roseus. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0071805"},{"key":"ref_8","first-page":"345","article-title":"Comparative studies concerning the tumour inhibition and the toxicology of vinblastine and vincristine","volume":"17","author":"Nemeth","year":"1970","journal-title":"Neoplasma"},{"key":"ref_9","first-page":"185","article-title":"Clinical experience with vinblastine and vincristine","volume":"21","author":"Cipriani","year":"1968","journal-title":"Cancro"},{"key":"ref_10","unstructured":"Editorial Committee of China Pharmacopoeia (2015). The Chinese Pharmacopoeia, Part I, China Chemical Industry Press. [2015 ed.]."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jep.2011.01.001","article-title":"The genus Epimedium: An ethnopharmacological and phytochemical review","volume":"134","author":"Ma","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ecam\/neh101","article-title":"The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro","volume":"2","author":"Xie","year":"2005","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/1381612822666151112145907","article-title":"Herba Epimedii: An Ancient Chinese Herbal Medicine in the Prevention and Treatment of Osteoporosis","volume":"22","author":"Wang","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_14","first-page":"530","article-title":"Action of the drug Herba Epimedii on testosterone of the mouse plasma and its accessory sexual organ before and after processing","volume":"14","author":"Niu","year":"1989","journal-title":"China J. Chin. Mater. Med."},{"key":"ref_15","first-page":"30","article-title":"Clinical observations on treatment of 120 cases of coronary heart disease with herba epimedii","volume":"12","author":"Yu","year":"1992","journal-title":"J. Tradit. Chin. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0254-6272(13)60012-6","article-title":"The effects of Chinese yam-epimedium mixture on respiratory function and quality of life in patients with chronic obstructive pulmonary disease","volume":"32","author":"Zhao","year":"2012","journal-title":"J. Tradit. Chin. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1440-1681.2004.03951.x","article-title":"Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth","volume":"31","author":"Lin","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.7150\/ijbs.11595","article-title":"Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells","volume":"11","author":"Khan","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/jssc.200700262","article-title":"Simultaneous determination of nine flavonoids and qualitative evaluation of Herba Epimedii by high performance liquid chromatography with ultraviolet detection","volume":"30","author":"Huang","year":"2007","journal-title":"J. Sep. Sci."},{"key":"ref_20","first-page":"466","article-title":"A review on research of raw material and cut crude drug of Herba epimedii in last ten years","volume":"32","author":"Pei","year":"2007","journal-title":"China J. Chin. Mater. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/0885328215581551","article-title":"Icariin: A promising osteoinductive compound for repairing bone defect and osteonecrosis","volume":"30","author":"Xie","year":"2015","journal-title":"J. Biomater. Appl."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.imbio.2014.12.015","article-title":"Regulation of Th17\/Treg function contributes to the attenuation of chronic airway inflammation by icariin in ovalbumin-induced murine asthma model","volume":"220","author":"Wei","year":"2015","journal-title":"Immunobiology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1248\/bpb.33.1307","article-title":"Icariin derivative inhibits inflammation through suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways","volume":"33","author":"Chen","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Xiong, W., Chen, Y., Wang, Y., and Liu, J. (2014). Roles of the antioxidant properties of icariin and its phosphorylated derivative in the protection against duck virus hepatitis. BMC Vet. Res., 10.","DOI":"10.1186\/s12917-014-0226-3"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-2006-959362","article-title":"Antihepatotoxic activity of icariin, a major constituent of Epimedium koreanum","volume":"61","author":"Lee","year":"1995","journal-title":"Planta Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuroscience.2015.02.053","article-title":"Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation","volume":"294","author":"Liu","year":"2015","journal-title":"Neuroscience"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2010.12.053","article-title":"Neuroprotective effects of icariin on corticosterone-induced apoptosis in primary cultured rat hippocampal neurons","volume":"1375","author":"Liu","year":"2011","journal-title":"Brain Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12013-015-0669-6","article-title":"Icariin Exerts Protective Effect Against Myocardial Ischemia\/Reperfusion Injury in Rats","volume":"73","author":"Meng","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s12013-014-0506-3","article-title":"Icariin Acts as a Potential Agent for Preventing Cardiac Ischemia\/Reperfusion Injury","volume":"72","author":"Zhai","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"ref_30","first-page":"3585","article-title":"Effects and mechanisms of icariin on atherosclerosis","volume":"8","author":"Hu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.fitote.2009.12.006","article-title":"Preparation of icariside II from icariin by enzymatic hydrolysis method","volume":"81","author":"Xia","year":"2010","journal-title":"Fitoterapia"},{"key":"ref_32","first-page":"4367","article-title":"Icariside II promotes osteogenic differentiation of bone marrow stromal cells in beagle canine","volume":"8","author":"Luo","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuroscience.2016.04.022","article-title":"Icariside II, a novel phosphodiesterase-5 inhibitor, attenuates streptozotocin-induced cognitive deficits in rats","volume":"328","author":"Yin","year":"2016","journal-title":"Neuroscience"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuint.2016.02.015","article-title":"Icariside II protects against cerebral ischemia-reperfusion injury in rats via nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor up-regulation","volume":"96","author":"Deng","year":"2016","journal-title":"Neurochem. Int."},{"key":"ref_35","first-page":"1124","article-title":"Antiproliferative activities of alcohol extracts of Herba Epimedii and Cortex Fraxini on breast cancer cell proliferation: In vitro study","volume":"18","author":"Chen","year":"2007","journal-title":"China Pharm."},{"key":"ref_36","first-page":"882","article-title":"Effects of Epimedium on rat tumor growth and bone destruction of breast cancer rats with bone metastasis","volume":"27","author":"Yao","year":"2008","journal-title":"Beijing J. Trad. Chin. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.3892\/mmr.2015.4282","article-title":"Anti-proliferative and cytoskeleton-disruptive effects of icariin on HepG2 cells","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2010.07.009","article-title":"Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS\/JNK-dependent mitochondrial pathway","volume":"298","author":"Li","year":"2010","journal-title":"Cancer Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2007.02.039","article-title":"A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells","volume":"564","author":"Huang","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.canlet.2009.02.024","article-title":"Cyclooxygenase-2\/prostaglandin E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells","volume":"280","author":"Lee","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Fan, C., Yang, Y., Liu, Y., Jiang, S., Di, S., Hu, W., Ma, Z., Li, T., Zhu, Y., and Xin, Z. (2016). Icariin displays anticancer activity against human esophageal cancer cells via regulating endoplasmic reticulum stress-mediated apoptotic signaling. Sci. Rep., 6.","DOI":"10.1038\/srep21145"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.3892\/or.2015.3891","article-title":"Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2","volume":"33","author":"Li","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10495-015-1142-0","article-title":"Activation of endoplasmic reticulum stress is involved in the activity of icariin against human lung adenocarcinoma cells","volume":"20","author":"Di","year":"2015","journal-title":"Apoptosis"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Song, J., Feng, L., Zhong, R., Xia, Z., Zhang, L., Cui, L., Yan, H., Jia, X., and Zhang, Z. (2016). Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt\/NF-kappaB signaling pathway. Mol. Carcinog.","DOI":"10.1002\/mc.22471"},{"key":"ref_45","first-page":"847","article-title":"Icariin Induced B16 Melanoma Tumor Cells Apoptosis, Suppressed Tumor Growth and Metastasis","volume":"43","author":"Li","year":"2014","journal-title":"Iran. J. Public Health"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3892\/mmr.2014.2701","article-title":"Icariside II inhibits cell proliferation and induces cell cycle arrest through the ROS-p38-p53 signaling pathway in A375 human melanoma cells","volume":"11","author":"Wu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/01635581.2013.741745","article-title":"Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways","volume":"65","author":"Wu","year":"2013","journal-title":"Nutr. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1016\/j.fct.2012.06.027","article-title":"Icariside II potentiates paclitaxel-induced apoptosis in human melanoma A375 cells by inhibiting TLR4 signaling pathway","volume":"50","author":"Wu","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"ref_49","first-page":"973","article-title":"Icariin induces apoptosis in mouse MLTC-10 Leydig tumor cells through activation of the mitochondrial pathway and down-regulation of the expression of piwil4","volume":"39","author":"Wang","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2010.03.017","article-title":"Icariin exterts negative effects on human gastric cancer cell invasion and migration by vasodilator-stimulated phosphoprotein via Rac1 pathway","volume":"635","author":"Wang","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_51","first-page":"123","article-title":"Icariin induces S-phase arrest and apoptosis in medulloblastoma cells","volume":"62","author":"Sun","year":"2016","journal-title":"Cell Mol. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zhang, C., Yang, L., Geng, Y.D., An, F.L., Xia, Y.Z., Guo, C., Luo, J.G., Zhang, L.Y., Guo, Q.L., and Kong, L.Y. (2016). Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1\u20134E-BP1 axis in sarcoma cells. Oncotarget.","DOI":"10.18632\/oncotarget.8538"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.canlet.2015.05.032","article-title":"Icariside II-induced mitochondrion and lysosome mediated apoptosis is counterbalanced by an autophagic salvage response in hepatoblastoma","volume":"366","author":"Geng","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.fct.2014.08.002","article-title":"Blockade of epidermal growth factor receptor\/mammalian target of rapamycin pathway by Icariside II results in reduced cell proliferation of osteosarcoma cells","volume":"73","author":"Geng","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejphar.2007.10.010","article-title":"Icariside II from Epimedium koreanum inhibits hypoxia-inducible factor-1alpha in human osteosarcoma cells","volume":"579","author":"Choi","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3892\/mmr.2013.1557","article-title":"Icariside II induces apoptosis via inhibition of the EGFR pathways in A431 human epidermoid carcinoma cells","volume":"8","author":"Wu","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Kang, S.H., Jeong, S.J., Kim, S.H., Kim, J.H., Jung, J.H., Koh, W., Kim, J.H., Kim, D.K., Chen, C.Y., and Kim, S.H. (2012). Icariside II induces apoptosis in U937 acute myeloid leukemia cells: Role of inactivation of STAT3-related signaling. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0028706"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1271\/bbb.120077","article-title":"Induction of apoptosis by Icariside II through extrinsic and intrinsic signaling pathways in human breast cancer MCF7 cells","volume":"76","author":"Huang","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2010.11.032","article-title":"Janus activated kinase 2\/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells","volume":"654","author":"Kim","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.intimp.2011.01.007","article-title":"Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions","volume":"11","author":"Zhou","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1142\/S0192415X09007569","article-title":"Anti-proliferative efficacy of icariin on HepG2 hepatoma and its possible mechanism of action","volume":"37","author":"Yang","year":"2009","journal-title":"Am. J. Chin. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s12013-014-0360-3","article-title":"Synergistic Anti-Cancer Effects of Icariin and Temozolomide in Glioblastoma","volume":"71","author":"Yang","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12013-015-0660-2","article-title":"Arsenic Trioxide and Icariin Show Synergistic Anti-leukemic Activity","volume":"73","author":"Wang","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12013-013-9724-3","article-title":"Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma","volume":"68","author":"Li","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1248\/bpb.b14-00663","article-title":"Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K\/Akt pathway","volume":"38","author":"Wang","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12013-014-9827-5","article-title":"Icariin-mediated inhibition of NF-kappaB activity enhances the in vitro and in vivo antitumour effect of 5-fluorouracil in colorectal cancer","volume":"69","author":"Shi","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/aps.2012.162","article-title":"Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-kappaB","volume":"34","author":"Zhang","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/0008-5472.CAN-05-3948","article-title":"TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer","volume":"66","author":"Kelly","year":"2006","journal-title":"Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/2594","article-title":"Understanding the cell cycle","volume":"4","author":"Nurse","year":"1998","journal-title":"Nat. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1747-1028-3-14","article-title":"Anti cancer effects of curcumin: Cycle of life and death","volume":"3","author":"Sa","year":"2008","journal-title":"Cell Div."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.274.5293.1664","article-title":"Cell cycle checkpoints: Preventing an identity crisis","volume":"274","author":"Elledge","year":"1996","journal-title":"Science"},{"key":"ref_72","first-page":"33","article-title":"The role of p53 in cell-cycle control and apoptosis: Implications for cancer","volume":"121","author":"Leonard","year":"1995","journal-title":"Important Adv. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00690207","article-title":"P53, cell cycle control and apoptosis: Implications for cancer","volume":"14","author":"Kastan","year":"1995","journal-title":"Cancer Metastasis Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1093\/emboj\/18.23.6845","article-title":"Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation","volume":"18","author":"Bulavin","year":"1999","journal-title":"EMBO J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2184.2003.00266.x","article-title":"The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer","volume":"36","author":"Vermeulen","year":"2003","journal-title":"Cell Prolif."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0065-230X(08)60352-8","article-title":"Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer","volume":"68","author":"Hall","year":"1996","journal-title":"Adv. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbapap.2005.08.019","article-title":"Exploiting structural principles to design cyclin-dependent kinase inhibitors","volume":"1754","author":"Noble","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: A review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nrc2663","article-title":"Apoptosis and cancer: The genesis of a research field","volume":"9","author":"Cotter","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","article-title":"Death receptors: Signaling and modulation","volume":"281","author":"Ashkenazi","year":"1998","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","article-title":"Cytotoxicity-Dependent Apo-1 (Fas\/Cd95)-Associated Proteins Form a Death-Inducing Signaling Complex (Disc) with the Receptor","volume":"14","author":"Kischkel","year":"1995","journal-title":"EMBO. J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1038\/sj.onc.1207523","article-title":"Toxic proteins released from mitochondria in cell death","volume":"23","author":"Saelens","year":"2004","journal-title":"Oncogene"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.neo.7900003","article-title":"The apoptosome: Heart and soul of the cell death machine","volume":"1","author":"Chinnaiyan","year":"1999","journal-title":"Neoplasia."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl2 family: Regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat. Rev. Cancer."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1042\/bst0290684","article-title":"Mechanisms of p53-dependent apoptosis","volume":"29","author":"Schuler","year":"2001","journal-title":"Biochem. Soc. Trans."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc776","article-title":"Death and anti-death: Tumour resistance to apoptosis","volume":"2","author":"Igney","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ccr.2004.09.003","article-title":"Nuclear factor-kappaB: The enemy within","volume":"6","author":"Aggarwal","year":"2004","journal-title":"Cancer Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0065-230X(06)97009-2","article-title":"Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis","volume":"97","author":"Cao","year":"2007","journal-title":"Adv. Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.3892\/mmr.2016.4813","article-title":"Icariin inhibits oxidized low-density lipoprotein-induced proliferation of vascular smooth muscle cells by suppressing activation of extracellular signal-regulated kinase 1\/2 and expression of proliferating cell nuclear antigen","volume":"13","author":"Hu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1073\/pnas.89.10.4309","article-title":"Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and\/or C-terminal tails","volume":"89","author":"Ekstrand","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2012.01.011","article-title":"Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locations","volume":"318","author":"Han","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_92","first-page":"6659","article-title":"Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells","volume":"62","author":"Mora","year":"2002","journal-title":"Cancer Res."},{"key":"ref_93","first-page":"594","article-title":"Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis","volume":"9","author":"Camp","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjc.6601003","article-title":"Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis","volume":"89","author":"Hsiao","year":"2003","journal-title":"Brit. J. Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0962-8924(00)01740-2","article-title":"Understanding Ras: \u2018It ain\u2019t over \u2018til it\u2019s over\u2019","volume":"10","author":"Shields","year":"2000","journal-title":"Trends Cell Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_99","first-page":"217","article-title":"Chronic inflammation and cancer","volume":"16","author":"Shacter","year":"2002","journal-title":"Oncology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4049\/jimmunol.176.1.284","article-title":"Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression","volume":"176","author":"Bunt","year":"2006","journal-title":"J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.surg.2012.02.017","article-title":"Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy","volume":"152","author":"Armstrong","year":"2012","journal-title":"Surgery"},{"key":"ref_102","first-page":"1276","article-title":"Expression of cyclooxygenase-2 in human gastric carcinoma","volume":"57","author":"Ristimaki","year":"1997","journal-title":"Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1097\/01.ju.0000107839.06670.27","article-title":"Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention","volume":"171","author":"Basler","year":"2004","journal-title":"J. Urol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/8\/9\/563\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:30:48Z","timestamp":1760211048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/8\/9\/563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,13]]},"references-count":103,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9]]}},"alternative-id":["nu8090563"],"URL":"https:\/\/doi.org\/10.3390\/nu8090563","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,13]]}}}